Current cost is not 3.45. That was for the whole quarter. Costs for June were 3.10.As production increases and becomes more efficient, costs naturally come down because they are fixed.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
